Skip to main content

Table 2 Treatments for chronic cystoid macular edema (cCME) and anatomical responses on spectral-domain optical coherence tomography

From: Macular edema after rhegmatogenous retinal detachment repair: risk factors, OCT analysis, and treatment responses

Type of treatment

Anti-VEGF

TA

DEX

 

Number of eyes

5

7

4

 

Number of Injections (Median; [Range])

2.5, 1-14

2.0, 1-10

2.5, 1-7

 

CST pre-injection (μm)

401 ± 84.9

481 ± 104

397 ± 57.0

P = 0.397

CST post-injection (μm)

393 ± 106

402 ± 102

355 ± 80.4

 

Percent CST change (μm)

− 1.44 ± 17.1, P = 0.915

− 15.6 ± 16.6, P = 0.016

− 11.0 ± 10.7, P = 0.434

 

Inner macular volume pre-injection (mm3)

2.81 ± 0.43

3.18 ± 0.56

3.12 ± 0.80

P = 0.457

Inner macular volume post-injection (mm3)

2.74 ± 0.53

2.72 ± 0.53

2.66 ± 0.486

 

Percent (%) inner macular volume change (mm3)

−2.49 ± 12.35, P = 0.828

−13.9 ± 10.8, P = 0.016

−10.7 ± 25.7, P = 0.125

 
  1. Values are listed as averages with standard deviations
  2. VEGF vascular endothelial growth factor, TA triamcinolone acetate, DEX dexamethasone implant, CST central subfield thickness